PTGX: Protagonist Therapeutics Inc
PTGX exchange rate has changed by -3.26% for today. During the day, the instrument was traded at a low of 81.4700 and at a high of 84.5400.
Follow Protagonist Therapeutics Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
PTGX News
- Protagonist Therapeutics, Inc. (PTGX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Alumis Stock Catapults More Than 110% As Biotech Takes On J&J, Protagonist In Psoriasis
- Truist raises Protagonist Therapeutics stock price target to $110 on pivotal year ahead
- Chasing Bubbles And Riding Value In Another Year Leading The S&P 500
- Protagonist Therapeutics stock hits all-time high at 93.53 USD
- Citizens maintains Protagonist Therapeutics stock rating, citing rusfertide efficacy
- Thanksgiving: Top 10 Most Innovative BioPharma Drugs In Phase 3
- Protagonist Therapeutics stock maintains Buy rating at Jefferies on pipeline potential
- Protagonist Therapeutics stock price target raised to $91 at Clear Street
- Protagonist Therapeutics (PTGX) Reports Q3 Loss, Lags Revenue Estimates
- Bolt Biotherapeutics, Inc. (BOLT) Expected to Beat Earnings Estimates: Should You Buy?
- Kymera Therapeutics, Inc. (KYMR) Reports Q3 Loss, Misses Revenue Estimates
- Protagonist Therapeutics (PTGX) Expected to Beat Earnings Estimates: Should You Buy?
- Truist Securities raises Protagonist Therapeutics stock price target to $88
- Regeneron (REGN) Q3 Earnings and Revenues Surpass Estimates
- Johnson & Johnson Q3 Earnings Surprise, Icotrokinra Shines Again (NYSE:JNJ)
- Johnson & Johnson To Separate Orthopedics Business, Boosts Annual Sales Outlook - Johnson & Johnson (NYSE:JNJ)
Frequently Asked Questions
What is PTGX stock price today?
Protagonist Therapeutics Inc stock is priced at 81.9900 today. It trades within 81.4700 - 84.5400, yesterday's close was 84.7500, and trading volume reached 1688. The live price chart of PTGX shows these updates.
Does Protagonist Therapeutics Inc stock pay dividends?
Protagonist Therapeutics Inc is currently valued at 81.9900. Dividend policy depends on the company, while investors also watch 9.13% and USD. View the chart live to track PTGX movements.
How to buy PTGX stock?
You can buy Protagonist Therapeutics Inc shares at the current price of 81.9900. Orders are usually placed near 81.9900 or 81.9930, while 1688 and -2.98% show market activity. Follow PTGX updates on the live chart today.
How to invest into PTGX stock?
Investing in Protagonist Therapeutics Inc involves considering the yearly range 74.0250 - 96.5400 and current price 81.9900. Many compare -5.26% and 9.13% before placing orders at 81.9900 or 81.9930. Explore the PTGX price chart live with daily changes.
What are Protagonist Therapeutics Inc stock highest prices?
The highest price of Protagonist Therapeutics Inc in the past year was 96.5400. Within 74.0250 - 96.5400, the stock fluctuated notably, and comparing with 84.7500 helps spot resistance levels. Track Protagonist Therapeutics Inc performance using the live chart.
What are Protagonist Therapeutics Inc stock lowest prices?
The lowest price of Protagonist Therapeutics Inc (PTGX) over the year was 74.0250. Comparing it with the current 81.9900 and 74.0250 - 96.5400 shows potential long-term entry points. Watch PTGX moves on the chart live for more details.
When did PTGX stock split?
Protagonist Therapeutics Inc has gone through stock splits historically. These changes are visible in , 84.7500, and 9.13% after corporate actions.
- Previous Close
- 84.7500
- Open
- 84.5100
- Bid
- 81.9900
- Ask
- 81.9930
- Low
- 81.4700
- High
- 84.5400
- Volume
- 1.688 K
- Daily Change
- -3.26%
- Month Change
- -5.26%
- 6 Months Change
- 9.13%
- Year Change
- 9.13%
- Act
- Fcst
- Prev